David Altshuler sold $1.6M of Vertex Pharmaceuticals Incorporated (VRTX)

Executed Mar 13 2025, disclosed Mar 17 2025, 4 days later.

Value, as filed

$1.6M

3,231 sh × $510.00

Executed

Mar 13 2025

the trade date, as filed

Disclosed

Mar 17 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

DA David Altshuler EVP, Chief Scientific Officer profile →

David Altshuler (EVP, Chief Scientific Officer) filed 6 Form 4 reports in the past 24 months (0 purchases, 6 sales), most often in Vertex Pharmaceuticals Incorporated (VRTX). The largest single filing was $1.6M of VRTX (3,231 sh × $510.00, as filed), executed Mar 13 2025.

The name

VRTX Vertex Pharmaceuticals Incorporated VRTX · Healthcare · 91 filings in 24 months ticker →

Healthcare · Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by David Altshuler in VRTX

VRTXSALE Vertex Pharmaceuticals Incorporated $1.6M
3,231 sh × $500.00
Exec Mar 10 2025
Filed Mar 12 2025 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $1.6M
3,231 sh × $490.00
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $611K
1,272 sh × $480.00
Exec Feb 27 2025
Filed Feb 28 2025 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $408K
848 sh × $480.95
Exec Feb 25 2025
Filed Feb 26 2025 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $533K
1,111 sh × $480.00
Exec Feb 20 2025
Filed Feb 24 2025 · 5:30 PM ET